LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Calciprotein Particles Induce Endothelial Dysfunction by Impairing Endothelial Nitric Oxide Metabolism.

    Feenstra, Lian / Kutikhin, Anton G / Shishkova, Daria K / Buikema, Hendrik / Zeper, Lara W / Bourgonje, Arno R / Krenning, Guido / Hillebrands, Jan-Luuk

    Arteriosclerosis, thrombosis, and vascular biology

    2023  Volume 43, Issue 3, Page(s) 443–455

    Abstract: Background: Calciprotein particles (CPPs) are associated with the development of vascular calcifications in chronic kidney disease. The role of endothelial cells (ECs) in this process is unknown. Here, we investigated the interaction of CPPs and ECs, ... ...

    Abstract Background: Calciprotein particles (CPPs) are associated with the development of vascular calcifications in chronic kidney disease. The role of endothelial cells (ECs) in this process is unknown. Here, we investigated the interaction of CPPs and ECs, thereby focusing on endothelial nitric oxide metabolism and oxidative stress.
    Methods: CPPs were generated in calcium- and phosphate-enriched medium. Human umbilical vein endothelial cells were exposed to different concentrations of CPPs (0-100 µg/mL) for 24 or 72 hours. Ex vivo porcine coronary artery rings were used to measure endothelial cell-dependent vascular smooth muscle cell relaxation after CPP exposure. Serum samples from an early chronic kidney disease cohort (n=245) were analyzed for calcification propensity (measure for CPP formation) and nitrate and nitrite levels (NO
    Results: CPP exposure for 24 hours reduced eNOS (endothelial nitric oxide synthase) mRNA expression and decreased nitrite production, indicating reduced nitric oxide bioavailability. Also, 24-hour CPP exposure caused increased mitochondria-derived superoxide generation, together with nitrotyrosine protein residue formation. Long-term (72 hours) exposure of human umbilical vein endothelial cells to CPPs induced eNOS uncoupling and decreased eNOS protein expression, indicating further impairment of the nitric oxide pathway. The ex vivo porcine coronary artery model showed a significant reduction in endothelial-dependent vascular smooth muscle cell relaxation after CPP exposure. A negative association was observed between NO
    Conclusions: CPPs cause endothelial cell dysfunction by impairing nitric oxide metabolism and generating oxidative stress. Our findings provide new evidence for direct effects of CPPs on ECs and pathways involved.
    MeSH term(s) Humans ; Animals ; Swine ; Nitric Oxide/metabolism ; Nitrites/metabolism ; Endothelium/metabolism ; Nitric Oxide Synthase Type III/metabolism ; Vascular Diseases ; Human Umbilical Vein Endothelial Cells/metabolism ; Renal Insufficiency, Chronic/metabolism ; Endothelium, Vascular/metabolism
    Chemical Substances Nitric Oxide (31C4KY9ESH) ; Nitrites ; Nitric Oxide Synthase Type III (EC 1.14.13.39)
    Language English
    Publishing date 2023-02-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1221433-4
    ISSN 1524-4636 ; 1079-5642
    ISSN (online) 1524-4636
    ISSN 1079-5642
    DOI 10.1161/ATVBAHA.122.318420
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Calciprotein Particles: Balancing Mineral Homeostasis and Vascular Pathology.

    Kutikhin, Anton G / Feenstra, Lian / Kostyunin, Alexander E / Yuzhalin, Arseniy E / Hillebrands, Jan-Luuk / Krenning, Guido

    Arteriosclerosis, thrombosis, and vascular biology

    2021  Volume 41, Issue 5, Page(s) 1607–1624

    Abstract: Figure: see text]. ...

    Abstract [Figure: see text].
    MeSH term(s) Animals ; Arteries/drug effects ; Arteries/metabolism ; Arteries/pathology ; Atherosclerosis/blood ; Atherosclerosis/etiology ; Atherosclerosis/pathology ; Atherosclerosis/prevention & control ; Biomarkers/blood ; Calcium/blood ; Calcium Chelating Agents/therapeutic use ; Crystallization ; Homeostasis ; Humans ; Hypercalcemia/blood ; Hypercalcemia/complications ; Hypercalcemia/drug therapy ; Hyperphosphatemia/blood ; Hyperphosphatemia/complications ; Hyperphosphatemia/drug therapy ; Phosphates/blood ; Risk Factors ; Vascular Calcification/blood ; Vascular Calcification/etiology ; Vascular Calcification/pathology ; Vascular Calcification/prevention & control
    Chemical Substances Biomarkers ; Calcium Chelating Agents ; Phosphates ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2021-03-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1221433-4
    ISSN 1524-4636 ; 1079-5642
    ISSN (online) 1524-4636
    ISSN 1079-5642
    DOI 10.1161/ATVBAHA.120.315697
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top